<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200206046395N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-05</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of massage therapy and Transcutaneous Electric Nerve Stimulation (TENS) on shoulder pain in patients after laparoscopic cholecystectomy</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of massage therapy and Transcutaneous Electric Nerve Stimulation (TENS) on shoulder pain in patients after laparoscopic cholecystectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>180</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61595</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Pre-sampling of the type will be available. Then, the samples studied in this study will be placed in the study groups (control, TENS intervention and massage intervention) using random allocation of patients. 
The random allocation sequence is determined using the block method with a volume of 6 using the software, Blinding description: The present study is double-blind because participants receiving the intervention are aware of the intervention. The data collector will not be aware of the patient group. The data analyzer will not be aware of the patient group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Laparoscopic cholecystectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Massage - Massage therapy group 30 minutes with three massage methods Petrisag-Kneading-Friction in the hand area. This technique is performed three times after cholecystectomy (4, 8 and 12 hours after surgery). Patients' pain intensity is measured and recorded 20 minutes before and after each massage with the Visual Pain Scale (VAS). Intervention 2: Intervention group: TENS In the TENS method, electrodes are placed near or on the shoulder pain site and send the stimuli created by the device to the skin to stimulate the sensory-nerve terminals. Also, in order to achieve effective and rapid pain relief, the TENS current (frequency of 150 Hz and a pulse width of 75 μs) Used for 30 minutes. the intensity of each channel was increased until the participant was able to feel a maximal tolerable tingling sensation without causing discomfort, pain, or muscle contraction.This technique is performed three times after cholecystectomy (4, 8 and 12 hours after surgery). Patients' pain intensity is measured and recorded 20 minutes before and after each TENS with a Visual Analogue Scale (VAS). Intervention 3: Control group: Get routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual participant data collected for the primary outcome measures

When:
After publication for one year

To whom:
For all people who request for data

Conditions:
It is allowed to perform any analysis on the data, but use of data for publication is not allowed.

Where to obtain:
Corresponding author of article

How to obtain:
After requesting the data by email to corresponding author , the data will be sent after a maximum period of one week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>MOBIN MOTTAHEDI</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Square of kargar_navvab</address>
        <city>shahrood</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3618675313</zip>
        <telephone>009832338090</telephone>
        <email>Mobinmottahedi1372@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>MOBIN MOTTAHEDI</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Square kargar-navvab</address>
        <city>shahrood</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3618675313</zip>
        <telephone>009832338090</telephone>
        <email>mobinmottahedi1372@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>A  VAS Shoulder pain intensity score at baseline (within 3 hours after surgery) of greater than or equal to 30 mm on a 100 mm VAS scale with 0 = no pain and 100 = worst pain imaginable.
According to the American Society of Anesthesiology (ASA) classification, the patient is in grade l or ll
consent to participate in oral and written research
Not to have internal cardiac pacemaker
Not pregnancy</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>having wounds, phlebitis, trauma arthritis in the massage area
Having a cognitive psychomotor disorder
Addiction to painkillers and opiates
Cardiovascular disease
Having shoulder pain before surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K91.86</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Retained cholelithiasis following cholecystectomy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Massage - Massage therapy group 30 minutes with three massage methods Petrisag-Kneading-Friction in the hand area. This technique is performed three times after cholecystectomy (4, 8 and 12 hours after surgery). Patients' pain intensity is measured and recorded 20 minutes before and after each massage with the Visual Pain Scale (VAS).</i_keyword>
      <i_keyword>Intervention group: TENS In the TENS method, electrodes are placed near or on the shoulder pain site and send the stimuli created by the device to the skin to stimulate the sensory-nerve terminals. Also, in order to achieve effective and rapid pain relief, the TENS current (frequency of 150 Hz and a pulse width of 75 μs) Used for 30 minutes. the intensity of each channel was increased until the participant was able to feel a maximal tolerable tingling sensation without causing discomfort, pain, or muscle contraction.This technique is performed three times after cholecystectomy (4, 8 and 12 hours after surgery). Patients' pain intensity is measured and recorded 20 minutes before and after each TENS with a Visual Analogue Scale (VAS).</i_keyword>
      <i_keyword>Control group: Get routine care</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Shoulder pain score in Visual Pain Scale Questionnaire. Timepoint: Before intervention,baseline (within 3 hours after surgery).4, 8 and 12 hours after surgery. Method of measurement: VAS Visual Analog Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Taking analgesic drugs. Timepoint: end of surgery. Method of measurement: check list.</sec_outcome>
      <sec_outcome>Time of the first dose of analgesic. Timepoint: end of surgery. Method of measurement: check list.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-11</approval_date>
        <contact_name>Ethics Committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Building No. 2 of Kermanshah University of Medical Sciences,Shahid beheshti Blvd Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
